Tatva Chintan Pharma Chem Limited IPO
Incorporated in 1996, Tatva Chintan Pharma Chem limited is a specialty chemicals manufacturing company that is engaged in the manufacturing of phase transfer catalysts (PTCs), structure-directing agents (SDAs), pharmaceutical & agrochemical intermediates or other specialty chemicals, and electrolyte salts for super-capacitor batteries. It is India’s largest & only commercial manufacturer of SDAs for zeolites.
Tatva Chintan Pharma Chem has a wide application of its products in various industries like petroleum, pharmaceutical, agro-chemicals, paints, and coatings. Apart from its customer base in India, it exports its products to more than 25 countries including USA, Germany, Japan, South Africa, China, etc.
It has two manufacturing facilities which are located in Ankleshwar and Dahej in Gujarat. Both are strategically located very close to the Hazira port.
The promoters of the company are Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani.
Strengths of the company
- Leading manufacturer of phase transfer catalysts and structure-directing agents
- Wide customer base with a global presence
- Diversified specialized product portfolio
- Modern manufacturing facilities with a focus on “green” chemistry process
- Strong R&D capabilities
Purpose of the IPO
- To fund the capital expenditure requirement for expansion of Dahej Manufacturing Facility.
- To fund the capital expenditure requirement for the R&D facility in Vadodara
- For general corporate purposes
Financial Performance of the company
| FY 2021 | FY 2020 | FY 2019 | |
| Total Revenue | 306.29 | 264.62 | 206.80 |
| Profit After Tax | 52.26 | 37.78 | 20.54 |
| Total Assets | 314.80 | 248.93 | 187.50 |
*All the values are in crores and as per RHP.
Valuation of the Company
| FY 2021 | FY 2020 | FY 2019 | |
| Basic Earnings per Share (EPS) | 26.02 | 18.81 | 10.23 |
| Diluted Earnings per Share (EPS) | 26.02 | 18.81 | 10.23 |
| Return on Net Worth (%) | 31.49% | 32.11% | 25.78% |
| Net Assets Value per Equity share | 82.62 | 58.59 | 39.68 |
*As per RHP.
Tatva Chintan Pharma Chem Limited IPO DRHP
Tatva Chintan Pharma Chem Limited IPO RHP
IPO details
| Face Value | ₹10 per equity share |
| Market Lot | 13 Shares |
| Minimum Order Quantity | 13 Shares |
| Price Band | ₹1,073- ₹1,083 per equity share |
| Issue type | Book Built Issue IPO |
| Issue Size | ₹500 Crores |
| Fresh Issue | ₹225 Crores |
| Offer for Sale | ₹275 Crores |
| Listing | NSE, BSE |
Important IPO dates
| Open Date | 16th July 2021 |
| Close Date | 20th July 2021 |
| Basis of Allotment Date | 26th July 2021 |
| Initiation of Refunds | 27th July 2021 |
| The credit of shares to Demat Account | 28th July 2021 |
| Listing Date | 29th July 2021 |
Allocation Quota
| Category | Portion |
| Qualified Institutional Buyers (QIBs) | Not more than 50% |
| Non- Institutional Buyers (NIIs) | Not less than 15% |
| Retail Investors | Not less than 35% |
Check your Tatva Chintan Pharma Chem Limited IPO allotment status here:
Link Intime IPO allotment Status: Click here
BSE IPO Allotment Status: Click here
NSE IPO Allotment Status: Click here.